Molecular imaging probes for 31P contrast
<p><sup>31</sup>P magnetic resonance has yet to realise its clinical potential principally due to the relatively low sensitivity of the <sup>31</sup>P nucleus. While <sup>31</sup>P-MRS can uniquely provide vital information regarding in vivo phosphorus met...
Κύριος συγγραφέας: | Tear, L |
---|---|
Άλλοι συγγραφείς: | Faulkner, S |
Μορφή: | Thesis |
Γλώσσα: | English |
Έκδοση: |
2018
|
Θέματα: |
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Magnetic Resonance Imaging Contrast Agents: A Review of Literature
ανά: Zahra Sahraei, κ.ά.
Έκδοση: (2015-10-01) -
Interval between contrast administration and T1-weighted MRI for cerebral adrenoleukodystrophy: a single-case observation
ανά: Marco Moscatelli, κ.ά.
Έκδοση: (2023-10-01) -
Comparison of gadolinium-based contrast agents for MR cholangiography in saline, blood and bile: a phantom study
ανά: Johannes M. Froehlich, κ.ά.
Έκδοση: (2023-04-01) -
Gadolinium-enhanced cardiovascular magnetic resonance: administered dose in relationship to united states food and drug administration (FDA) guidelines
ανά: Nacif Marcelo S, κ.ά.
Έκδοση: (2012-02-01) -
Toxicity associated with gadolinium-based contrast-enhanced examinations
ανά: Silvia Maria Lattanzio
Έκδοση: (2021-05-01)